2014;53(9):e4001
What stands out: Enforcement focus on mass-marketing, not patient-specific compounding Clear limits on advertising claims, including prohibitions on calling compounded products generic, the same as, or clinically proven Reinforcement of FD&C Act authorities, including misbranding provisions and Section 503A requirements Shift as shortages resolve, removing the legal basis for broad compounding of GLP-1 drugs Expanded compliance tools, including warning letters, seizure, and injunction where violations persist Bottom line: This signals a firmer FDA posture as the GLP-1 market matures, reinforcing long-standing distinctions between FDA-approved drugs and unapproved compounded preparations, particularly when promoted directly to consumers at scale
It contains protein and all essential amino acids , making it an excellent plant-based protein source
It is not a drug and does not replicate the pharmacological effect of prescription GLP-1 medications
Entre los beneficios esperables, expresados en trminos de bienestar y apoyo nutricional, se incluyen: Ingredientes por dosis diaria ( 20 ml ): Fructooligosacridos 400 mg , procedentes de mezcla de frutas y verduras
Hydration is your best ally here